CRVO
CervoMed Inc.NASDAQHealthcare$4.14-3.86%ClosedMarket Cap: $38.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.02
P/S
114.24
EV/EBITDA
-1.02
DCF Value
$20.10
FCF Yield
-63.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-8771.7%
Net Margin
-8359.9%
ROE
-96.0%
ROA
-115.2%
ROIC
-151.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-8.3M | $-8.1M | $-0.87 | — |
| FY 2025 | $4.0M | 0.0% | $-28.3M | $-27.0M | $-2.98 | — |
| Q3 2025 | $322.6K | 100.0% | $-8.0M | $-7.7M | $-0.84 | — |
| Q2 2025 | $0.00 | NaN% | $-6.6M | $-6.3M | $-0.70 | — |
| Q1 2025 | $0.00 | NaN% | $-5.3M | $-4.9M | $-0.56 | — |
| Q4 2024 | $0.00 | NaN% | $-7.2M | $-6.7M | $-0.77 | — |
| FY 2024 | $0.00 | NaN% | $-18.2M | $-16.3M | $-2.02 | — |
| Q3 2024 | $0.00 | NaN% | $-5.4M | $-4.8M | $-0.55 | — |
| Q2 2024 | $0.00 | NaN% | $-3.0M | $-2.3M | $-0.27 | — |
| Q1 2024 | $0.00 | NaN% | $-2.6M | $-2.5M | $-0.41 | — |
| Q4 2023 | $0.00 | NaN% | $-2.5M | $-2.4M | $-0.42 | — |
| FY 2023 | $0.00 | NaN% | $-7.8M | $-2.2M | $-0.82 | — |